Zoledronic acid sodium can treat osteoporosis.
The drug is a new bisphosphonate preparation that inhibits osteoclastogenesis and inhibits bone resorption for the treatment of osteoporosis.
Zoledronate is a third-generation bisphosphonate, and common adverse reactions are bone pain, fever, fatigue, arthralgia, myalgia, hypocalcemia, and renal impairment and osteonecrosis of the jaws, so renal function should be checked before use.
If loosening of teeth, pain, swelling, difficult to heal mouth ulcers occur during use, the drug should be discontinued. It is contraindicated for those who are allergic to zoledronic acid, other bisphosphonates, pregnant and lactating women.
For those who suffer from osteoporosis, it is recommended to go to the orthopedic department or endocrinology department of the hospital for treatment under the guidance of the doctor, and not to use the drug blindly.